Allergan Tazoral PACT Program Will Register, Certify Physicians/Pharmacies
This article was originally published in The Pink Sheet Daily
Executive Summary
Mandatory pregnancy prevention registry will issue ID numbers upon physician/pharmacist certification and patient qualification. Tazarotene efficacy shown in moderate to severe psoriasis, but not in very severe disease, FDA says. Agency expresses concern about off-label use in acne.